马燕 (Yan Ma)

University of Kansas教授

H指数:25

被引数:2,766

个人简介

"广东省科技专家库专家\n广东省高层次人才评审专家\n广州市科技专家库专家\n国家自然科学基金评审专家\n教育经历\n[1]2003.09-2006.06 沈阳药科大学-博士\n[2]2000.09-2003.06 沈阳药科大学-硕士\n[3]1996.09-2000.06 沈阳药科大学-学士\n工作经历\n[1]2017.01-至今，广州中医药大学-教授\n[2] 2010.01-2016.12，广州中医药大学-副教授\n[3] 2012.12-2013.12，美国北卡罗来纳大学（教堂山）-访问学者\n[4]2006.07-2009.12，广州中医药大学-讲师\n研究方向：聚焦于药物新剂型与递送系统的设计，并深入探究其与药物体内吸收规律及药效发挥之间的内在关联。\n研究领域：新型靶向递药系统的研究\n联系方式：mayan2006@gzucm.edu.cn\n研究课题\n[1]单硫醚键介导的氧化还原敏感性多西他赛-亚油酸前药自组装纳米粒的开发，广州市科技计划项目，20万， 2019/04-2021/03，结题，主持。\n[2]一种制备方法简单的刺激响应型双功能复合纳米药物制剂的研究，广东省科技计划项目，2016/06-2019/05，30万，结题，主持。\n[3]基于改善难溶性药物及其制剂口服生物利用度的新技术研究，广东省科技计划项目，2015/06-2018/05，20万，结题，主持。\n[4]多功能鸦胆子油分子配型组装纳米乳逆转肿瘤多药耐药的研究，国家自然科学基金项目，2015/01-2017/12，23万元，结题，主持。\n[5]复方紫杉醇多功能纳米给药系统靶向逆转肿瘤多药耐药性的研究，广东省医学科学技术研究基金项目，2015/07-2017/06，0.5万，结题，主持。\n[6]广州中医药大学“青年英才培养工程”，2015/01-2018/12，20万，结题，主持。\n[7]多功能分子配型组装纳米给药系统抗肿瘤分子机制的研究，广州中医药大学“薪火计划”项目，2014/11-2016/12，5万，结题，主持。\n主编或参编教材及著作\n[1]《中药药剂学》，科学出版社，副主编\n[2]《药用高分子材料学》，中国中医药出版社，编委\n[3]《药剂学》，中国中医药出版社，编委\n代表性论文论著\n[1] Xiaofeng Guo, Shuni Zeng, Qiwei Chen, et. al. Brucea javanica-derived natural lipid droplets: selective oral lymph targeting and endocytic transport mechanisms, Pharmaceutics, 2026, 18(2): 260.（唯一通讯作者）\n[2] Xiaofeng Guo, Shuni Zeng, Qiaoyu Huang, et. al. Lipid Droplet-Mediated Extraction of Perilla Seed Oil: Stability, Absorbability and Carrier Potential. Lipids, 2025, 60(6):481-490.（唯一通讯作者）\n[3] Quandong Li, Xinru Chen, Wen Lin, et. al. Application of a novel multicomponent nanoemulsion to tumor therapy Based on the theory of “unification of drugs and excipients”. Pharmaceutical Development and Technology, 2023, 28 (3-4):351-362.（唯一通讯作者）\n[4] Xinru Chen, Quandong Li, Zipeng Huang, et. al. Construction and evaluation of curcumin upconversion nanocarriers decorated with MnO2 for tumor photodynamic therapy. Drug Delivery and Translational Research, 2022, 12(11):2678-2692.（唯一通讯作者）\n[5] Zipeng Huang, Xinru Chen, Ying Li, et. al. Excogitation and assessment of curcumin-vitamin E self-assembly PEGylated nanoparticles by the route of oral administration. Journal of Pharmaceutical Sciences, 2021, 110 (1): 146-154.（共同通讯作者）\n[6] Yan Ma, Liuting Zhong, Zhuo Peng, et. al. Development of a highly water-soluble lycopene cyclodextrin ternary formulation by the integrated experimental and modeling techniques. AAPS PharmaSciTech, 2020, 22 (1):5.（共同第一作者）\n[7] Yan Ma, DongYang Zhang, Zhuo Peng, et. al. Delivery of Platinum (IV) prodrugs via Bi2Te3 nanoparticles for photothermal-chemotherapy and photothermal/photoacoustic imaging. Molecular Pharmaceutics, 2020, 17(12):3403-3411. （共同第一作者）\n[8] Ying Li, Pei Xiao, Zipeng Huang, et. al. Evaluation of curcumin-mediated photodynamic therapy on the reverse of multidrug resistance in tumor cells. RSC Advances, 2020, 10:298-306. （共同通讯作者）\n[9] Junqiu Zhai, Qingguo Li, Huahua Xu, et. al. An aseptic one-shot bottom-up method to produce progesterone nanocrystals: controlled size and improved bioavailability. Molecular Pharmaceutics, 2019, 16 (12):5076-5084. （共同通讯作者）\n[10] Xia Yan, Shuqing Cao, Ying Li, et. al. Internalization and subcellular transport mechanisms of different curcumin loaded nanocarriers across Caco-2 cell model. Journal of Drug Delivery Science and Technology, 2019, 52: 660-669. （共同通讯作者）\n[11] Shuqing Cao, Kuanyun Zhang, Xia Yan, et. al. Preparation and evaluation of Paclitaxel and Brucea Javanica oil core-matched nanoemulsions to treat cancer in vitro and in vivo, Chinese Herbal Medicines, 2018, 10(3): 310-317.（唯一通讯作者）\n[12] Yan Ma, Dan Liu, Dun wang, et. al. Combinational delivery of Hydrophobic and Hydrophilic Anticancer Drugs in Single Nanoemulsions to Treat MDR in Cancer，Molecular Pharmaceutics，2014, 11:2623-2630（共同第一作者）\n其他代表性业绩\n无"